Jakobsen, Gunnhild http://orcid.org/0000-0002-4914-7623
Engstrøm, Morten
Hjermstad, Marianne Jensen
Rosland, Jan Henrik
Aass, Nina
Albert, Eva
Kaasa, Stein
Fayers, Peter
Klepstad, Pål
Paulsen, Ørnulf
Funding for this research was provided by:
Telemark Hospital trust and the South-Eastern Norway Regional Health Authority
Liason Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology
Article History
Received: 3 April 2020
Accepted: 19 August 2020
First Online: 27 August 2020
Compliance with ethical standards
:
: The funders had no role in the trial design, collection, analysis and interpretation of data, or writing.
: Marianne Jensen Hjermstad, Jan Henrik Rosland, Nina Aass, Eva Albert, Peter Fayers, and Pål Klepstad have nothing to disclose. Ørnulf Paulsen has received PhD grant from the Telemark Hospital Trust and the South-Eastern Norway Regional Health Authority. Gunnhild Jakobsen has received PhD grant from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). Morten Engstrøm has received lecture fees and support for travel from ResMed and Philips. Stein Kaasa is one of the shareholders in Eir Solution A/S and has research funding from Nutricia for other studies. The authors declare no income, dividend, or financial benefits from the work presented here.
: Ethical approval was given for the primary study by the Regional Committee for Medical Research Central Norway (4.2007.846). All patients were informed about the nature of the study and provided written informed consent to participate. The study was conducted in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: Not applicable